StaphOff Biotech logo

StaphOff Biotech

StaphOff has developed a completely unique approach to fighting staphylococcal infections using a first-in-class heptapeptide known as RNAIII Inhibiting Peptide (RIP) or CEN-101, and non-peptide analogues like CEN-103.

Industries

Employees

1-10

Links


Org chart

Collapse

Board & advisors


Teams


Offices